enGene Holdings Inc.
Developing non-viral, locally administered gene therapies for rare genetic conditions.
ENGN | US
Overview
Corporate Details
- ISIN(s):
- CA29286M1059
- LEI:
- Country:
- United States of America
- Address:
- 4868 RUE LEVY, SUITE 220, SAINT-LAURENT
- Website:
- https://engene.com/
- Sector:
- Manufacturing
Description
enGene Holdings Inc. is a clinical-stage biotechnology company focused on developing and commercializing non-viral, locally administered gene therapies. The company aims to mainstream genetic medicine by delivering therapeutics directly to mucosal tissues to treat a variety of diseases, with an initial focus on rare genetic conditions. Leveraging its proprietary drug delivery platform, enGene's mission is to improve the lives of patients by advancing a pipeline of innovative genetic treatments. The company began trading publicly in November 2023.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all enGene Holdings Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for enGene Holdings Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for enGene Holdings Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
